MorphoSys AG IPO Research Information

MorphoSys AG IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on MorphoSys AG, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
MorphoSys AG	MOR - NASDAQ	$24.12-$24.12	$25.04	$26.16	8.3 million ADSs	4/19/2018
Underwriter(s): Goldman Sachs & Co., J.P. Morgan, Leerink Partners
Co-Manager(s): Berenberg Capital Markets, JMP Securities
Industry: Health Care
Filing(s): Filed 2018-03-22 Terms Added 2018-04-09 Final Prospectus 2018-04-19

MorphoSys AG Quote & Chart - Click for current quote - MOR

About MorphoSys AG (adapted from MorphoSys AG prospectus):
They are a late-stage biopharmaceutical company devoted to the development of innovative and differentiated therapies for patients suffering from serious diseases. Their shares are listed on the Frankfurt Stock Exchange under the symbol 'MOR'.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "MOR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.